Others

Brawn Biotech Ltd. - Outcome of Board Meeting

| Updated on February 11, 2019 Published on February 11, 2019

Pursuant to provisions of Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015, we would like to inform you that in the Meeting of the Board of Directors of the company held today, 11 February, 2019 inter alia considered the
following:
1. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements)Regulation, 2015, Board approved the Unaudited Financial Results for quarter and nine month ended 31 December, 2018. Copy of the results is enclosed herewith as Annexure- I.
2. Limited Review Report on Unaudited Financial Results for the quarter and nine months ended on 31 December, 2018 obtained from the Statutory Auditor has also been taken on
record and copy of the same is enclosed herewith as Annexure- II.

Pdf Link: Brawn Biotech Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on February 11, 2019
This article is closed for comments.
Please Email the Editor